IN2015DN02999A - - Google Patents

Info

Publication number
IN2015DN02999A
IN2015DN02999A IN2999DEN2015A IN2015DN02999A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A IN 2999DEN2015 A IN2999DEN2015 A IN 2999DEN2015A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A
Authority
IN
India
Prior art keywords
field
relates
medicine
glucocorticoids
medicament
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Aven
Balazs Albrecht
Benjamin Franzmann
Matthias Hausmann
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IN2015DN02999A publication Critical patent/IN2015DN02999A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IN2999DEN2015 2012-12-21 2013-12-18 IN2015DN02999A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13190393 2013-10-25
PCT/EP2013/077266 WO2014096116A1 (en) 2012-12-21 2013-12-18 Pharmaceutical formulation comprising ciclesonide

Publications (1)

Publication Number Publication Date
IN2015DN02999A true IN2015DN02999A (enExample) 2015-09-25

Family

ID=49779929

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2999DEN2015 IN2015DN02999A (enExample) 2012-12-21 2013-12-18

Country Status (10)

Country Link
US (3) US10925964B2 (enExample)
EP (2) EP2934544B1 (enExample)
AU (1) AU2013360692B2 (enExample)
CA (1) CA2888431C (enExample)
DK (2) DK3473255T3 (enExample)
ES (2) ES2909039T3 (enExample)
IN (1) IN2015DN02999A (enExample)
LT (2) LT3473255T (enExample)
MX (1) MX364652B (enExample)
WO (1) WO2014096116A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2934544B1 (en) 2012-12-21 2018-11-07 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical formulation comprising ciclesonide
HRP20181980T1 (hr) 2012-12-21 2019-01-25 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za liječenje dišnih puteva kod konja
KR102618119B1 (ko) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물
KR102435599B1 (ko) 2016-06-02 2022-08-29 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체
RS61994B1 (sr) 2017-12-01 2021-07-30 Abbvie Inc Agonist glukokortikoidnog receptora i njegovi imunokonjugati

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) * 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
JP2006528228A (ja) * 2003-05-22 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
WO2006003078A1 (en) * 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR101641520B1 (ko) 2009-06-25 2016-07-21 베링거잉겔하임베트메디카게엠베하 흡입기
US20150202297A1 (en) 2012-07-05 2015-07-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
HRP20181980T1 (hr) 2012-12-21 2019-01-25 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za liječenje dišnih puteva kod konja
EP2934544B1 (en) 2012-12-21 2018-11-07 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical formulation comprising ciclesonide
EP4257171A3 (en) 2013-08-20 2023-11-22 Boehringer Ingelheim Vetmedica GmbH Inhaler
HRP20201987T1 (hr) 2013-08-20 2021-02-05 Boehringer Ingelheim Vetmedica Gmbh Inhalator
KR102618119B1 (ko) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물

Also Published As

Publication number Publication date
US20210106685A1 (en) 2021-04-15
MX364652B (es) 2019-05-03
EP3473255B1 (en) 2022-01-12
DK2934544T3 (en) 2019-03-04
LT3473255T (lt) 2022-03-10
CA2888431A1 (en) 2014-06-26
US11819549B2 (en) 2023-11-21
AU2013360692B2 (en) 2018-08-09
WO2014096116A1 (en) 2014-06-26
MX2015007731A (es) 2015-09-07
LT2934544T (lt) 2019-02-25
US10925964B2 (en) 2021-02-23
EP2934544A1 (en) 2015-10-28
EP3473255A1 (en) 2019-04-24
DK3473255T3 (da) 2022-04-04
EP2934544B1 (en) 2018-11-07
US20140179650A1 (en) 2014-06-26
US20240024482A1 (en) 2024-01-25
CA2888431C (en) 2021-10-19
ES2909039T3 (es) 2022-05-05
AU2013360692A1 (en) 2015-04-23
ES2706757T3 (es) 2019-04-01

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12016500094A1 (en) Autotaxin inhibitors
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
PH12015502002B1 (en) Tripeptide epoxy ketone protease inhibitors
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
HK1221418A1 (zh) 释放修饰药物的水凝胶-连接的前药
IN2015DN03984A (enExample)
EP4360621A3 (en) Formulations of bendamustine
JO3326B1 (ar) مثبطات إيبوكسي كيتون بروتياز ثلاثي الببتيد
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
WO2013112959A8 (en) Antifibrotic compounds and uses thereof
MX2015004362A (es) Derivados de ketamina.
ZA201505318B (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
IN2015DN02999A (enExample)
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX390369B (es) Inhibidores tripeptidicos de la epoxicetona proteasa
IN2013CH04314A (enExample)
MD4291B1 (ro) Preparat medicamentos pentru tratamentul otitelor
MX366763B (es) Composiciones farmacéuticas de montelukast y levocetirizina.
UA74882U (uk) Фармацевтична композиція для лікування сексуальної дисфункції